@misc{Rayman_G-2021_6840,
title = {Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes},
author = {Rayman, G. and Lumb, A. and Kennon, B. and Cottrell, C. and Nagi, D. and Page, E. and Voigt, D. and Courtney, H. and Atkins, H. and Platts, J. and Higgins, K. and Dhatariya, K. and Patel, M. and Narendran, P. and Kar, P. and Newland-Jones, P. and Stewart, R. and Burr, O. and Thomas, S.},
month = {jan},
year = {2021},
abstract = {The RECOVERY (Randomised Evaluation of COVid-19 thERapY) trial found that dexamethasone 6 mg once per day for 10 days reduced deaths by one-third in ventilated patients and by one-fifth in other patients, receiving oxygen therapy. This equates to the prevention of one death in around eight ventilated patients, or one in around 25 patients requiring oxygen.},
volume = {38 },
issue = {1},
journal = {Diabetic Medicine },
publisher = {Wiley},
url = {https://doi.org/10.1111/dme.14378},
}
